Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
04/01/2008 | CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
04/01/2008 | CA2272361C Polyether-modified polyisocyanate mixtures having improved dispersibility in water |
03/27/2008 | WO2008036211A1 Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety |
03/27/2008 | WO2008035726A1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
03/27/2008 | WO2008035378A2 An improved process for the preparation of thalidomide |
03/27/2008 | WO2008035377A2 Novel intermediates for the preparation of camptothecin analogues |
03/27/2008 | WO2008035306A1 3 -amino- pyridine derivatives for the treatment of metabolic disorders |
03/27/2008 | WO2008035209A2 Quinoline and quinazoline derivatives as inhibitors of protein tyrosine kinase activity |
03/27/2008 | WO2008035189A1 A method for the purification of lansoprazole |
03/27/2008 | WO2008034863A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
03/27/2008 | WO2008034600A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
03/27/2008 | WO2008034579A1 2-heterocyclyl-5-phenoxymethylpyridine derivatives as anticancer agents |
03/27/2008 | WO2008034272A1 Stilbazolium salt |
03/27/2008 | WO2008021928A3 Hepatitis c virus inhibitors |
03/27/2008 | WO2008010934A3 Triazolyl phenyl benzenesulfonamides |
03/27/2008 | WO2008009405A3 Novel pyridazine derivatives |
03/27/2008 | WO2008008431A3 Heteroaryl sulfonamides and ccr2/ccr9 |
03/27/2008 | WO2008005489A3 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
03/27/2008 | WO2008002674A3 Bicyclic compositions and methods for modulating a kinase cascade |
03/27/2008 | WO2008002671A3 Metalloprotease inhibitors |
03/27/2008 | WO2007141200A8 Novel n-aryl and n-heteroaryl substituted pyridinone derivatives for use in mch-1 mediated diseases |
03/27/2008 | WO2007136668A9 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
03/27/2008 | WO2007103370A3 Quinazoline derivatives as phosphodiesterase 10 inhibitors |
03/27/2008 | WO2007094513A3 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
03/27/2008 | WO2007036717A8 4- (4-BROMO-2-FLUOROANILINO) -6-METHOXY-7- (l-METHYLPIPERIDIN-4 -YLMETHOXY) QUINAZOLINE MONOHYDRATE |
03/27/2008 | WO2007020411A8 Amide derivatives |
03/27/2008 | WO2006125621A8 Substituted piperidines as renin inhibitors |
03/27/2008 | US20080076930 Novel stereoselective synthesis of benzimidazole sulfoxides |
03/27/2008 | US20080076929 Novel stereoselective synthesis of benzimidazole sulfoxides |
03/27/2008 | US20080076924 P2X7 purinergic receptor; pain, arthritis, autoimmune diseases, neurodegenerative diseases; N-aminothiocarbonyl-piperazines, N-aminocarbonylpiperazines, or cyanoguanidine-functional piperazines |
03/27/2008 | US20080076918 Quinoxaline compounds |
03/27/2008 | US20080076914 Method of Deprotection |
03/27/2008 | US20080076817 Neurotrophic N-glyoxyl-prolyl ester compounds e.g. 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; non-immunosuppressive; side effect reduction; neurodegenerative diseases |
03/27/2008 | US20080076815 Sulfonamide or sulfonimide functional indazole or indole compounds such as N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydryoxyethyl]phenyl]methanesulfonamide; diabetes, obesity, hyperlipidemia and urinary incontinence |
03/27/2008 | US20080076802 Vinylaminopyrazole derivatives as pesticides |
03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
03/27/2008 | US20080076788 Solid forms of (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of their use |
03/27/2008 | US20080076787 Crystalline antifungal compounds |
03/27/2008 | US20080076783 Cycloalkyl Keto Piperidine Tachykinin Receptor Antagonists |
03/27/2008 | US20080076777 Piperazine Derivatives and Their Use in Controlling Pests |
03/27/2008 | US20080076773 Such as (3R,4R)-1-Pyrimidin-4-yl-4-(2,4,5-trifluorophenyl)piperidin-3-amine bis-trifluoroacetic acid salt |
03/27/2008 | US20080076767 Controlling cell proliferation, cell differentiation,autoimmune disease; N-[4-(3-amino-1,2-benzisoxazol-4-yl)phenyl]-N'-(3-methylphenyl)urea; 2-[4-(3-amino-1H-indazol-4-yl)phenyl]-N-(3-chlorophenyl)acetamide; N-[4-(3-amino-1,2-benzisothiazol-4-yl)phenyl]-N'-(3,5-dimethylphenyl)urea; anticarcinogenic |
03/27/2008 | US20080076759 Therapeutic Heterocyclic Compounds 507 |
03/27/2008 | US20080076044 Compound or its tautomer, metal complex compound, colored photosensitive curing composition, color filter, and production |
03/27/2008 | DE102006042143A1 Neue substituierte Bipyridin-Derivate und ihre Verwendung New substituted bipyridine derivatives and their use |
03/27/2008 | CA2663943A1 3-amino-pyridine derivatives for the treatment of metabolic disorders |
03/27/2008 | CA2662838A1 Oxindole derivatives |
03/27/2008 | CA2662484A1 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
03/27/2008 | CA2662359A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
03/27/2008 | CA2662348A1 Indolylalkylpyridin-2-amines for the inhibition of .beta.-secretase |
03/26/2008 | EP1903039A1 Injection |
03/26/2008 | EP1903038A1 N-(1-hetaryl-piperidin-4-yl)-(het)arylamide as EP2 receptor modulators |
03/26/2008 | EP1903037A1 1-(hetero)aryl-3-[heteroaryl-piperidin-4yl]-thiourea derivatives as modulators of EP2 receptors |
03/26/2008 | EP1902717A2 Vasopressin antagonist and oxytocin antagonist |
03/26/2008 | EP1902052A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
03/26/2008 | EP1902047A2 Carboxamide compound and use of the same |
03/26/2008 | EP1902046A1 Piperidine derivatives useful as histamine h3 antagonists |
03/26/2008 | EP1902045A1 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament |
03/26/2008 | EP1902044A1 5-htx modulators |
03/26/2008 | EP1902032A1 Pharmaceutical compounds |
03/26/2008 | EP1902028A2 Histamine h3 receptor antagonists |
03/26/2008 | EP1902026A2 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
03/26/2008 | EP1902025A1 Kinase inhibitors |
03/26/2008 | EP1901752A2 Compositions and methods for viral inhibition |
03/26/2008 | EP1901743A1 Quinoline derivatives as antibacterial agents |
03/26/2008 | EP1901731A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
03/26/2008 | EP1901608A1 Substituted arylpyrazoles as parasiticidal agents |
03/26/2008 | EP1751132B1 2-substituted pyrimidines and their use as pesticides |
03/26/2008 | EP1716133B1 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors |
03/26/2008 | EP1696924B1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
03/26/2008 | EP1583763B1 Benzoazolylpiperazine derivatives having vr1-antagonist activity |
03/26/2008 | EP1562934B1 Amino-heterocycles as vr-1 antagonists for treating pain |
03/26/2008 | EP1556362B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
03/26/2008 | EP1196396B1 Pharmacologically active compounds with two covalently linked active principles (sodium channnel blocker/p2y2 receptor agonist) for the treatment of mucosal surfaces |
03/26/2008 | CN101151258A Pyrimidine derivatives for treatment of hyperproliferative disorders |
03/26/2008 | CN101151253A Substituted n-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators |
03/26/2008 | CN101151252A Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
03/26/2008 | CN101151251A Substituted pyrazolyl oxyphenyl derivatives used as herbicides |
03/26/2008 | CN101151249A Cyclopentapyridine and tetrahydroquinoline derivatives |
03/26/2008 | CN101151248A 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
03/26/2008 | CN101151244A Histamine H3 receptor agents, preparation and therapeutic uses |
03/26/2008 | CN101151239A Novel biaromatic compounds, inhibitors of the P2X7-receptor |
03/26/2008 | CN100376572C Anti-infective agents |
03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |
03/26/2008 | CN100376567C Qinazoline derivatives as VEGF inhibitors |
03/26/2008 | CN100376566C Delta1-pyrrolines compound |
03/26/2008 | CN100376565C Method for preparing fused oxazinones |
03/26/2008 | CN100376557C Quinoline derivatives as ligands for the neuropeptide y receptor |
03/26/2008 | CN100376554C N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
03/26/2008 | CN100376246C Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
03/25/2008 | US7348448 Substituted phenyl esters; dementia |
03/25/2008 | US7348440 Mitotic kinesin inhibitors |
03/25/2008 | US7348434 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
03/25/2008 | US7348427 Substituted with an amido heterocylic groups; infection by Gram-positive bacteria. |
03/25/2008 | US7348357 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
03/25/2008 | US7348355 Treating obesity with the Microsomal triglyceride transfer protein inhibitor (S) N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and another lipid lowering agent such as a statin or fibrate |
03/25/2008 | US7348353 Acetylene derivatives having mGluR 5 antagonistic activity |
03/25/2008 | US7348350 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesirable microorganisms |